← Back to directory

Sergey M. Deyev

Researcher Next ID · RN-042722

Researcher · Engineering

Russian Academy of Sciences

Moscow, New Zealand

Accepting doctoral researchersFunding unknown
Works count
384
Citation count
7,802
H-index
45
i10-index
180

Research interests

Engineering
Materials Science
Medicine
Monoclonal and Polyclonal Antibodies Research
Nanoplatforms for cancer theranostics
HER2/EGFR in Cancer Research
Radiopharmaceutical Chemistry and Applications
Nanoparticle-Based Drug Delivery

Publications

  • Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors

    Advanced Drug Delivery Reviews · 2025 · 10.1016/j.addr.2025.115550

  • Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery

    Nature Communications · 2024 · 10.1038/s41467-024-48838-5

  • Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors

    Light Science & Applications · 2022 · 10.1038/s41377-022-00729-4

  • Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission

    Pharmaceutics · 2022 · 10.3390/pharmaceutics14051013

  • Long-Term Fate of Magnetic Particles in Mice: A Comprehensive Study

    ACS Nano · 2021 · 10.1021/acsnano.1c00687

  • Laser-synthesized TiN nanoparticles for biomedical applications: Evaluation of safety, biodistribution and pharmacokinetics

    Materials Science and Engineering C · 2020 · 10.1016/j.msec.2020.111717

  • Fast processes of nanoparticle blood clearance: Comprehensive study

    Journal of Controlled Release · 2020 · 10.1016/j.jconrel.2020.07.014

  • Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes

    Nature Biomedical Engineering · 2020 · 10.1038/s41551-020-0581-2

  • In vivo blockade of mononuclear phagocyte system with solid nanoparticles: Efficiency and affecting factors

    Journal of Controlled Release · 2020 · 10.1016/j.jconrel.2020.12.004

  • Plants with genetically encoded autoluminescence

    Nature Biotechnology · 2020 · 10.1038/s41587-020-0500-9

  • Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth

    Nanoscale · 2018 · 10.1039/c8nr07730d

  • Neuroblastoma Origin and Therapeutic Targets for Immunotherapy

    Journal of Immunology Research · 2018 · 10.1155/2018/7394268

  • Radioactive ( 90 Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer

    Proceedings of the National Academy of Sciences · 2018 · 10.1073/pnas.1809258115

  • Deep-penetrating photodynamic therapy with KillerRed mediated by upconversion nanoparticles

    Acta Biomaterialia · 2017 · 10.1016/j.actbio.2017.01.004

  • Riboflavin photoactivation by upconversion nanoparticles for cancer treatment

    Scientific Reports · 2016 · 10.1038/srep35103

  • Cytotoxicity and non-specific cellular uptake of bare and surface-modified upconversion nanoparticles in human skin cells

    Nano Research · 2015 · 10.1007/s12274-014-0641-6

  • Biocomputing based on particle disassembly

    Nature Nanotechnology · 2014 · 10.1038/nnano.2014.156

  • Genetically Encoded Immunophotosensitizer 4D5scFv-miniSOG is a Highly Selective Agent for Targeted Photokilling of Tumor Cells in Vitro

    Theranostics · 2013 · 10.7150/thno.6715

  • Feasibility study of the optical imaging of a breast cancer lesion labeled with upconversion nanoparticle biocomplexes

    Journal of Biomedical Optics · 2013 · 10.1117/1.jbo.18.7.076004

  • Protein-assisted self-assembly of multifunctional nanoparticles

    Proceedings of the National Academy of Sciences · 2010 · 10.1073/pnas.1001142107

  • Modern Technologies for Creating Synthetic Antibodies for Clinical Application

    Acta Naturae · 2009 · 10.32607/20758251-2009-1-1-32-50

  • Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein

    Proceedings of the National Academy of Sciences · 2009 · 10.1073/pnas.0904140106

  • Barnase as a New Therapeutic Agent Triggering Apoptosis in Human Cancer Cells

    PLoS ONE · 2008 · 10.1371/journal.pone.0002434

  • Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design

    BioEssays · 2008 · 10.1002/bies.20805

  • Design of multivalent complexes using the barnase·barstar module

    Nature Biotechnology · 2003 · 10.1038/nbt916

Current projects

    No projects listed.